Canada markets open in 7 hours 42 minutes

Medexus Pharmaceuticals Inc. (P731.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.0800-0.0800 (-6.90%)
At close: 08:01AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
Total Revenue
115,725
108,096
76,701
79,660
Cost of Revenue
54,499
48,058
38,774
37,655
Gross Profit
61,226
60,038
37,927
42,005
Operating Expenses
Research Development
8,532
9,032
11,309
9,338
Selling General and Administrative
39,646
42,164
38,596
31,430
Total Operating Expenses
48,437
51,549
50,303
41,274
Operating Income or Loss
12,789
8,489
-12,376
731
Interest Expense
14,752
13,606
12,223
9,816
Total Other Income/Expenses Net
1,091
76
20,779
-22,416
Income Before Tax
-872
-5,041
-3,820
-31,501
Income Tax Expense
-6,752
-6,262
-941
-3,237
Income from Continuing Operations
5,880
1,221
-2,879
-28,264
Net Income
5,880
1,221
-2,879
-28,264
Net Income available to common shareholders
5,880
1,221
-2,879
-28,264
Basic EPS
0.25
0.06
-0.15
-1.86
Diluted EPS
0.25
0.06
-0.15
-1.86
Basic Average Shares
20,160
19,976
19,454
15,197
Diluted Average Shares
20,708
20,524
19,856
15,197